Literature DB >> 477768

The role of hemin in the regulation of heme synthesis by fetal mouse liver erythroblasts in culture.

Z Malik, H Bessler, M Djaldetti.   

Abstract

The regulatory role of exogenous hemin on the heme synthetic pathway was studied in fetal mouse liver erythroblasts in culture. Hemin added to culture medium of 13th day embryo liver cells inhibited, dose dependently, the incorporation of the porphyrin precursors, 59Fe, 14C-2-glycine and 14C-5-aminolevulinic acid (ALA) by 85%, 70% and 45%, respectively. This suggests a multiple effect of hemin on the porphyrin biosynthetic enzymes. Exogenous ALA competed with 14 C-2-glycine as a porphyrin precursor, but the rate of heme synthesis, measured by 59Fe incorporation, remained unaltered. Protoporphyrin mimicked the hemin effect on the inhibition of glycine incorporation into heme, but reduced iron incorporation by only 20%. Erythroblasts, with an inhibited porphyrin biosynthesis, utilized exogenous 59Fe-hemin for hemoglobin assembly and maintained an undecreased level of hemoglobin synthesis. The results indicate that hemin inhibits the porphyrin biosynthesis in fetal mouse liver erythroblasts mainly at the iron incorporation stage.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 477768

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  3 in total

1.  Colony formation by primitive hemopoietic progenitor cells in serum-free medium.

Authors:  J F Eliason; N Odartchenko
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

2.  Expression of ferrochelatase mRNA in erythroid and non-erythroid cells.

Authors:  R Y Chan; H M Schulman; P Ponka
Journal:  Biochem J       Date:  1993-06-01       Impact factor: 3.857

3.  New Insights into the Pivotal Role of Iron/Heme Metabolism in TLR4/NF-κB Signaling-Mediated Inflammatory Responses in Human Monocytes.

Authors:  Dong Young Kang; Nipin Sp; Eun Seong Jo; Jin-Moo Lee; Kyoung-Jin Jang
Journal:  Cells       Date:  2021-09-27       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.